EGCG similarly protects SH-SY5Y human neuroblastoma cells from amyloid precursor protein (APP), 3-hydroxykynurenine, or 6-hydroxydopamine (6-OHDA) toxicity [35,36,37], and rescues rat PC12 cells from serum withdrawal or paraquat-induced apoptosis [38,39]. The gene discussed is APP; the disease is neuroblastoma.